Results 28,661-28,680 of 46,575 for speaker:Simon Harris

Questions on Promised Legislation (21 Feb 2018)

Simon Harris: I thank Deputy Ferris. I appreciate the importance of that sensitive matter and the need for parents to have assurance and certainty on it. As he said, the Minister of State, Deputy McGrath, has met the group and I am sure he will do so again as he said. I will pass on Deputy Ferris's concerns to him directly.

Questions on Promised Legislation (21 Feb 2018)

Simon Harris: I thank Deputy Healy-Rae for raising that matter and bringing those two personal cases to my attention. I am very sorry for the experience those people had-----

Questions on Promised Legislation (21 Feb 2018)

Simon Harris: -----in Cork and in Kerry as well. He might send me the details regarding them. The Government is very clear on what it intends to do. We do not have a health service that is the appropriate size in terms of meeting the needs of our population. That means we will need more beds in the health service and that is the reason we approved, as part of Project Ireland 2040, the delivery of 2,600...

Questions on Promised Legislation (21 Feb 2018)

Simon Harris: I will follow up in regard to Sativex and directly revert to Deputy Kenny. As regards access to cannabis, I have now signed five licences to provide patients in this country------

Questions on Promised Legislation (21 Feb 2018)

Simon Harris: Yes, I signed another last week. Every valid licence application I have received has been signed and processed in an efficient manner. As regards the compassionate access programme, Deputy Kenny is correct that there has been great progress in the clinical guidelines now being drawn up. However, the issue is now to try to source a product------

Questions on Promised Legislation (21 Feb 2018)

Simon Harris: I also have a very good source in the Department of Health and I have the guidelines-------

Questions on Promised Legislation (21 Feb 2018)

Simon Harris: I have the guidelines and great work has been done by the clinical expert group that I set up to put in place a compassionate access programme. However, guidelines are only of use if we can access products and my Department is currently working on how we can access an appropriate product to the benefit of Irish patients.

Questions on Promised Legislation (21 Feb 2018)

Simon Harris: I appreciate Deputy Harty's question and his medical knowledge in this regard. However, there is no blanket ban in regard to Versatis being provided off-licence. In fact, as the Taoiseach already outlined to the House, over 850 patients have been approved for off-licence use during the clinical process where a GP has lodged an appeal with the medicines management programme. Approximately...

Written Answers — Department of Health: Health Services Reports (21 Feb 2018)

Simon Harris: The Sláintecare report represents a significant milestone in our political and health policy history.  It is the first time in the history of the State that cross-party consensus of this scale has been achieved on health policy. It provides a once in a generation opportunity to achieve the most comprehensive reform of our health services ever undertaken and to improve...

Written Answers — Department of Health: Health Services Reports (21 Feb 2018)

Simon Harris: The Committee on the Future of Healthcare engaged the Centre for Health Policy in Trinity College Dublin to assist it with its deliberations. As part of this process, the Centre provided indicative costings for a range of recommended actions and these are outlined in the report. The Committee acknowledge in the report that these costings are only indicative, and that further work will be...

Written Answers — Department of Health: Health Services Reports (21 Feb 2018)

Simon Harris: The Sláintecare report, produced by the Committee on the Future of Healthcare, represents a significant milestone in our political and health policy history. It is the first time that cross-party consensus of this scale has been achieved on health policy. It provides a once in a generation opportunity to achieve the most comprehensive reform of our health services ever undertaken and to...

Written Answers — Department of Health: Hospital Charges (21 Feb 2018)

Simon Harris: My Department is currently considering the issue of the application of the public in-patient charge of €80 for venesection in Acute Hospitals as well as broader issues in relation to the treatment of patients with Hereditary Haemochromatosis. A meeting involving relevant personnel in the HSE and the Department of Health is being arranged in that regard.

Written Answers — Department of Health: Hospital Appointments Status (21 Feb 2018)

Simon Harris: Under the Health Act 2004, the Health Service Executive (HSE) is required to manage and deliver, or arrange to be delivered on its behalf, health and personal social services. Section 6 of the HSE Governance Act 2013 bars the Minister for Health from directing the HSE to provide a treatment or a personal service to any individual or to confer eligibility on any individual. The National...

Written Answers — Department of Health: General Practitioner Services Provision (21 Feb 2018)

Simon Harris: As this question relates to a service matter, I have arranged for the question to be referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: National Treatment Purchase Fund Payments (21 Feb 2018)

Simon Harris: As set out in the NTPF Audited Annual Financial Statements for 2016, the total expenditure by the NTPF in 2016 was €34,287,621, made up of €30,387,932 for patient care, and €3,899,689 for administrative expenses. The NTPF did not have a direct role in the commissioning of patient treatments in 2016. The procurement of treatments was carried out by the HSE...

Written Answers — Department of Health: National Treatment Purchase Fund Data (21 Feb 2018)

Simon Harris: The NTPF has provided the following information in relation to their expenditure on Private and Voluntary Hospitals, both inside and outside the State, in the years from 2011 to 2016. Year  Expenditure 2016 €30,387,932 2015 €21,345,689 2014 €0 2013 €4,262,636 2012 €22,999,528 2011 €56,784,944 Please note that the NTPF 2017 and...

Written Answers — Department of Health: Cross-Border Health Initiatives (21 Feb 2018)

Simon Harris: The Directive on Patients' Rights in Cross Border Healthcare provides rules for the reimbursement of patients' of the cost of receiving treatment abroad, where the patient would be entitled to such treatment in their home Member State (Member State of Affiliation) and supplements the rights that patients already have at EU level through the legislation on the coordination of social security...

Written Answers — Department of Health: Health Services Provision (21 Feb 2018)

Simon Harris: Under the Health Act 2004, the Health Service Executive (HSE) is required to manage and deliver, or arrange to be delivered on its behalf, health and personal social services.  Section 6 of the HSE Governance Act 2013 bars the Minister for Health from directing the HSE to provide a treatment or a personal service to any individual or to confer eligibility on any individual. As this...

Written Answers — Department of Health: Hospital Appointments Administration (21 Feb 2018)

Simon Harris: Under the Health Act 2004, the Health Service Executive (HSE) is required to manage and deliver, or arrange to be delivered on its behalf, health and personal social services. Section 6 of the HSE Governance Act 2013 bars the Minister for Health from directing the HSE to provide a treatment or a personal service to any individual or to confer eligibility on any individual. The National...

Written Answers — Department of Health: Medicinal Products Availability (21 Feb 2018)

Simon Harris: The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. On 11 July 2014, the Misuse of Drugs Regulations 1988 were amended to allow for certain cannabis-based medicinal products to be used in Ireland. The Health Products Regulatory Authority...